Ultra short manic-like episodes after antidepressant augmentation with modafinil

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 3, 2008, Pages 891-892

  Fountoulakis, K N ^a   Siamouli, M ^a   Panagiotidis, P ^a   Magiria, S ^a   Kantartzis, S ^a   Iacovides, A ^a   Kaprinis, G S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DONEPEZIL; LITHIUM; MODAFINIL; NEUROLEPTIC AGENT; VALPROIC ACID; VENLAFAXINE;

ADULT; BIPOLAR I DISORDER; BRAIN DISEASE; CASE REPORT; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EUPHORIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERACTIVITY; LETTER; MAJOR DEPRESSION; MALE; MANIA; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; SIDE EFFECT; THYROID FUNCTION;

ANTIDEPRESSIVE AGENTS; BENZHYDRYL COMPOUNDS; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; MIDDLE AGED;

EID: 39749110133     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.11.006     Document Type: Letter

References (14)

1. Benazzi F. Mania associated with donepezil. Int J Geriatr Psychiatry 13 11 (1998) 814-815
2. Benazzi F. Mania associated with donepezil. J Psychiatry Neurosci 24 5 (1999) 468-469
3. Benazzi F., and Rossi E. Mania and donepezil. Can J Psychiatry 44 5 (1999) 506-507
4. Burt T. Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents. Curr Psychiatry Rep 2 6 (2000) 473-478
5. Burt T., Sachs G.S., and Demopulos C. Donepezil in treatment-resistant bipolar disorder. Biol Psychiatry 45 8 (1999) 959-964
6. DeBattista C., Lembke A., Solvason H.B., Ghebremichael R., and Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol 24 1 (2004) 87-90
7. Fava M., Thase M.E., Debattista C., Doghramji K., Arora S., and Hughes R.J. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry 19 3 (2007) 153-159
8. Frye M.A., Grunze H., Suppes T., McElroy S.L., Keck Jr. P.E., Walden J., et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 164 8 (2007) 1242-1249
9. Konuk N., Atasoy N., Atik L., and Akay O. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors. Adv Ther 23 4 (2006) 646-654
10. Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and 128 Q1 effects on cognition. Neuropsychopharmacology in press.
11. Narendran R., Young C.M., Valenti A.M., Nickolova M.K., and Pristach C.A. Is psychosis exacerbated by modafinil?. Arch Gen Psychiatry 59 3 (2002) 292-293
12. Nasr S. Modafinil as adjunctive therapy in depressed outpatients. Ann Clin Psychiatry 16 3 (2004) 133-138
13. Thase M.E., Fava M., DeBattista C., Arora S., and Hughes R.J. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr 11 2 (2006) 93-102
14. Wolf J., Fiedler U., Anghelescu I., and Schwertfeger N. Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil. J Clin Psychiatry 67 11 (2006) 1817